Doctor profile · Federal record

Dr. Miguel Garcia-Caro, M.D.

Rheumatology Physician (CMS: Rheumatology) · Alexandria, LA

  • NPI 1508859455
  • Accepts Medicare
  • MIPS 95.3 / 100 · 2023
  • 45 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
146 Yorktown Dr
Alexandria, LA 713033621
(318) 416-5060
fax (318) 416-5064

Credentials & registration

NPPES · NUCC
NPI registered
August 2005 — 21 yrs on file
Profile last updated
October 10, 2015
Year of graduation
1981 — 45 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Louisiana #07117R
Medicaid
LA #1358428

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1508859455. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
63,591
Distinct HCPCS
10
Medicare allowed
$1,413,072
HCPCS Description Services Patients Avg allowed
J1602 Injection, golimumab, 1 mg, for intravenous use 45,797 45 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 12,050 15 $42
J0897 Injection, denosumab, 1 mg 2,280 22 $23
99213 Established patient office or other outpatient visit, 20-29 minutes 1,574 388 $84
96413 Administration of chemotherapy into vein, 1 hour or less 675 97 $116
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 476 85 $1
J3489 Injection, zoledronic acid, 1 mg 155 31 $9
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 120 26 $7
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 110 29 $65
99214 Established patient office or other outpatient visit, 30-39 minutes 105 77 $119

In context: peer comparison

Among 1 peers in this city , average services per provider: 4,542. This provider delivers 14× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,477
Transactions
75
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 25 $644.75
Janssen Biotech, Inc. 15 $230.83
ANI Pharmaceuticals, Inc. 8 $142.68
Mallinckrodt Hospital Products Inc. 7 $111.55
GlaxoSmithKline, LLC. 5 $94.66
UCB, Inc. 3 $59.70
Galderma Laboratories, L.P. 3 $51.29
AstraZeneca Pharmaceuticals LP 3 $44.78
PFIZER INC. 2 $34.91
E.R. Squibb & Sons, L.L.C. 1 $16.71
Aurinia Pharma U.S., Inc. 1 $16.69
ABBVIE INC. 1 $14.88
Takeda Pharmaceuticals U.S.A., Inc. 1 $13.82

By nature of payment

Food and Beverage
$1,477

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
5,018
Patients
958
Total drug cost
$101,929
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 1,042 147 $24,046
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 511 60 $16,063
Duloxetine Hcl Generic 439 86 $7,757
Gabapentin Generic 407 72 $6,265
Tramadol Hcl Generic 350 75 $3,387
Methotrexate (Methotrexate Sodium) Brand 310 77 $5,015
Baclofen Generic 290 66 $4,470
Pregabalin Generic 254 44 $10,169
Hydroxychloroquine Sulfate Generic 238 52 $8,776
Prednisone Generic 230 86 $1,614

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Miguel Garcia-Caro's medical specialty?
Dr. Miguel Garcia-Caro practices Rheumatology Physician in Alexandria, LA.
Where does Dr. Miguel Garcia-Caro practice?
Dr. Miguel Garcia-Caro practices at 146 Yorktown Dr, Alexandria, LA 713033621. Office phone: 3184165060.
What is Dr. Miguel Garcia-Caro's NPI?
Dr. Miguel Garcia-Caro's National Provider Identifier (NPI) is 1508859455, issued by NPPES.
Does Dr. Miguel Garcia-Caro accept Medicare assignment?
Yes. Dr. Miguel Garcia-Caro accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Miguel Garcia-Caro commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.